semaglutide for type 1 diabetes could remove need insulin injections in diabetes, promising study shows A Review on Semaglutide: An

Can be taken anytime without the need for water or food

Peak athletic performance takes discipline and commitment to a well-designed training program, a nutrient-dense diet, and the best available recovery strategies

Patients ...

India today has over 100 million people living with diabetes and nearly 250 million affected by obesity, positioning the country among the largest potential markets for metabolic therapies globally

The #FDA approved the first oral GLP-1 receptor agonist, semaglutide (#Wegovy pill), for chronic weight management in adults with obesity or overweight with comorbidities, offering a noninjectable alternative with significant weight loss benefits

In a 48-week clinical trial in obese adults, it showed weight reduction of up to 24.2%.